Credit: Children's Hospital of Philadelphia Oncology researchers studying high-risk children's cancers have identified a protein that offers a likely target for immunotherapy--harnessing ..
Credit: {FEATUREDCREDIT}{FEATUREDCREDITMORE} WASHINGTON, D.C., September 11, 2017 -- Researchers are starting to discover the curing powers of plasma -- bringing the ion-based form of matter...
Liver cancer occurs predominantly in patients whose liver has been damaged as a result of chronic disease. Until now it has remained in the dark...
PHILADELPHIA -- (Sept. 11, 2017) -- T lymphocytes found in tumors and implicated in killing tumor cells cope with the shortage of oxygen and nutrients...
Credit: Photo courtesy of: UCLA Jonsson Comprehensive Cancer Center Scientists at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at...
Credit: Baylor College of Medicine The discovery of a mechanism by which normal brain cells regulate the expression of the NFIA gene, which is important...
Milan, 11 September 2017 - The names of the 2017 Balzan Prizewinners were disclosed today in a public announcement: Aleida and Jan Assmann (Germany), Universities...
CHAPEL HILL -- A study by researchers at the University of North Carolina Eshelman School of Pharmacy and Lineberger Comprehensive Cancer Center determined the cost...
Credit: Karl Harrison A team of scientists led by the University of Southampton has demonstrated a groundbreaking new method of gene synthesis - a vital...
LUGANO-MADRID, 11 September, 2017 - Combination targeted adjuvant therapy with dabrafenib and trametinib doubles relapse-free survival in patients with stage III BRAF-mutant melanoma, according to...
LUGANO-MADRID, 11 September, 2017 - Adjuvant nivolumab is superior to standard of care ipilimumab in patients with surgically resected stage III/IV melanoma who are at...
LUGANO-MADRID, 11 September, 2017 - Immunotherapy with the checkpoint inhibitor pembrolizumab may be a better option than standard treatments for patients whose head and neck...
LUGANO-MADRID, 11 September, 2017 - The debate on whether to shorten adjuvant chemotherapy for colon cancer from six to three months takes centre stage today...
LUGANO-MADRID, 10 September, 2017 - Ramucirumab plus docetaxel improves progression-free survival in patients with advanced or metastatic urothelial cancer who have progressed on platinum-based chemot..
LUGANO-MADRID, 10 September, 2017 - Mature results from the KEYNOTE-045 trial to be presented today at the ESMO 2017 Congress in Madrid (1) have confirmed...
